DNM1L and neoplasm: RUNX1 in mitochondria. In a mouse model with both RUNX1 mutation and CBL exon deletion increased Drp1-dependent mitochondrial fission and ROS production in the tumor cells, leading to impaired granulopoiesis dysplasia and an overall MDS phenotype.